Skip to main content
GNLXHealthcare

Genelux Corp (GNLX) Insider Trading

In the last 90 days, 3 Genelux Corp (GNLX) insiders reported no open-market purchases and 6 sales totaling $159,421. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 31, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 31, 2026Joseph CappelloChief Technical OfficerSale10,257$2.74$28,112
Aug 31, 2026Thomas ZindrickPresident and CEOSale34,463$2.67$91,899
Aug 31, 2026Yong YuChief Scientific OfficerSale9,683$2.75$26,658
Aug 4, 2026Yong YuChief Scientific OfficerSale653$2.94$1,922
Aug 4, 2026Joseph CappelloChief Technical OfficerSale653$2.95$1,924
Aug 4, 2026Thomas ZindrickPresident and CEOSale3,023$2.95$8,905
Jul 1, 2026John W SmitherCorporate insiderSale12,000$2.91$34,898
Jun 3, 2026Ralph SmallingHead of RegulatorySale192$2.93$562.56
Jun 1, 2026John ThomasCorporate insiderSale10,000$2.98$29,801
May 11, 2026Joseph CappelloChief Technical OfficerSale605$2.97$1,799

Common questions

GNLX insider trading FAQ

Are GNLX insiders buying or selling?
Over the last 90 days, GNLX insiders were net sellers, reporting $0.00 of open-market purchases and $159,421 of sales.
When was the last GNLX insider purchase?
No open-market insider purchase of Genelux Corp stock was reported in the last 90 days.
Where does GNLX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Genelux Corp officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.